Is label-free LC-MS/MS ready for biomarker discovery?

Area of Science:

• Proteomics
• Biomarker Discovery
• Mass Spectrometry

Background:

• Label-free liquid chromatography-mass spectrometry (LC-MS) is a powerful tool for high-throughput quantitative proteomics.
• Its straightforward sample processing and scalability make it suitable for large-scale clinical studies and biomarker discovery.
• However, the research community exhibits hesitation in adopting these methods for clinical proteomics.

Purpose of the Study:

• To discuss the advantages and disadvantages of label-free LC-MS/MS for biomarker discovery.
• To outline the essential requirements for the successful implementation of label-free LC-MS/MS.
• To highlight successful applications of label-free LC-MS/MS in identifying novel biomarkers.

Main Methods:

• Review and discussion of label-free LC-MS/MS methodologies.
• Analysis of prerequisites for successful clinical proteomics studies using label-free approaches.
• Compilation of case studies demonstrating successful biomarker identification.

Main Results:

• Label-free LC-MS/MS offers significant advantages for high-throughput quantitative proteomics and biomarker discovery.
• Key prerequisites for successful application include robust data analysis pipelines and standardized workflows.
• Several studies successfully identified novel biomarkers using label-free LC-MS/MS, demonstrating its potential.

Conclusions:

• Label-free LC-MS/MS is a viable and increasingly accepted technique for clinical proteomics.
• Addressing current hesitations through clear guidelines and successful case studies will foster wider adoption.
• The future likely holds increased utilization of label-free methods in biomarker discovery.